Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Syndax Pharmaceuticals Inc (1T3.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
26.60+0.80 (+3.10%)
At close: 02:29PM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
126,576
139,709
1,517
1,517
Operating Expense
140,551
113,489
72,940
59,056
Operating Income
-13,975
26,220
-71,423
-57,539
Net Non Operating Interest Income Expense
-112
-1,496
-1,516
1,571
Other Income Expense
141
202
-219
-79
Pretax Income
-13,946
24,926
-73,158
-56,047
Net Income Common Stockholders
-13,946
24,926
-77,064
-56,047
Diluted NI Available to Com Stockholders
-13,946
24,926
-77,064
-56,047
Basic EPS
-
0.48
-1.87
-1.84
Diluted EPS
-
0.48
-1.87
-1.84
Basic Average Shares
-
52,065
41,308
30,491
Diluted Average Shares
-
52,065
41,308
30,491
Total Operating Income as Reported
-13,975
26,220
-71,423
-57,539
Total Expenses
140,551
113,489
72,940
59,056
Net Income from Continuing & Discontinued Operation
-13,946
24,926
-73,158
-56,047
Normalized Income
-13,946
24,926
-73,158
-56,047
Interest Income
2,975
403
841
-
Interest Expense
3,087
1,899
2,357
-
Net Interest Income
-112
-1,496
-1,516
1,571
EBIT
-10,859
26,825
-70,801
-57,539
EBITDA
-10,819
-
-
-
Reconciled Depreciation
40
43
89
92
Net Income from Continuing Operation Net Minority Interest
-13,946
24,926
-73,158
-56,047
Normalized EBITDA
-10,819
26,868
-70,712
-57,447
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement